Sujie Zhu - Publications

Vitiligo Signature-Based Drug Screening Identifies Fulvestrant as a Novel Immunotherapy Combination Strategy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 06, 2025

Comprehensive Analysis of the Function and Prognostic Value of TAS2Rs Family-Related Genes in Colon Cancer.

Journal: International journal of molecular sciences

Published: April 26, 2024

Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy.

Journal: Cell communication and signaling : CCS

Published: March 27, 2024

The role of corneal endothelium in macular corneal dystrophy development and recurrence.

Journal: Science China. Life sciences

Published: February 09, 2023

Identification of immunotherapy and chemotherapy-related molecular subtypes in colon cancer by integrated multi-omics data analysis.

Journal: Frontiers in immunology

Published: January 11, 2023

Comprehensive analysis of novel cancer prediction genes and tumor microenvironment infiltration in colon cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 21, 2022

The natural product rotundic acid treats both aging and obesity by inhibiting PTP1B.

Journal: Life medicine

Published: July 03, 2022

MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer.

Journal: Computational and structural biotechnology journal

Published: April 30, 2022

Conformational Constrained 4-(1-Sulfonyl-3-indol)yl-2-phenylaminopyrimidine Derivatives as New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations.

Journal: Journal of medicinal chemistry

Published: April 21, 2022

The genetic algorithm-aided three-stage ensemble learning method identified a robust survival risk score in patients with glioma.

Journal: Briefings in bioinformatics

Published: April 20, 2022

An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia.

Journal: Leukemia

Published: February 04, 2022

A novel histone deacetylase inhibitor exerts promising anti-breast cancer activity via triggering AIFM1-dependent programmed necrosis.

Journal: Cancer communications (London, England)

Published: January 14, 2022